Key Findings
- Fasting blood glucose decreased by 17.8 mg/dL on average vs placebo (p < 0.001)
- Total cholesterol reduced by 15.6 mg/dL and LDL by 14.1 mg/dL across trials
- Triglycerides decreased by 20.6 mg/dL, with greater effects at doses ≥2g/day
- HbA1c showed a mean reduction of 0.45% in diabetic populations over 8-12 weeks
- Modest weight loss of 1.76 kg was observed in trials lasting 8+ weeks